Nattokinase

Nattokinase is a fibrinolytic enzyme derived from natto (fermented soybeans) that directly breaks down fibrin to support cardiovascular health. The enzyme works by cleaving fibrin clots and activating plasminogen, promoting healthy blood circulation and reducing thrombotic risk.

Origin & History

Nattokinase is an enzyme derived from natto, a traditional Japanese food made from fermented soybeans. It is produced through the fermentation process involving the bacterium Bacillus subtilis var. natto.

Historical & Cultural Context

Nattokinase has been used in Japan for centuries as part of the traditional diet, known for its cardiovascular benefits.

Health Benefits

- Supports cardiovascular health by promoting healthy blood circulation and reducing blood viscosity, which may lower the risk of clot formation. - Aids in the breakdown of fibrin, a protein involved in blood clotting, helping to maintain clear arteries and optimal blood flow. - May reduce blood pressure by improving vascular flexibility and decreasing arterial stiffness, as shown in studies with reductions of up to 10%. - Enhances heart health by lowering LDL cholesterol and triglyceride levels, contributing to a healthier lipid profile. - Supports healthy aging by protecting against oxidative stress and inflammation, both linked to cardiovascular disease. - May improve recovery after physical exertion by reducing muscle soreness and supporting efficient circulation. - Promotes brain health by supporting microcirculation, which can enhance cognitive function and mental clarity. - Helps maintain normal platelet function, reducing the risk of unwanted clotting events.

How It Works

Nattokinase directly cleaves fibrin through its serine protease activity, breaking down existing blood clots and preventing new clot formation. The enzyme also activates tissue plasminogen activator (tPA) and converts plasminogen to plasmin, enhancing the body's natural fibrinolytic system. Additionally, nattokinase inhibits plasminogen activator inhibitor-1 (PAI-1), further promoting clot dissolution.

Scientific Research

Clinical trials and observational studies support its role in cardiovascular health, particularly in promoting blood flow and reducing clot formation.

Clinical Summary

Human studies using 2000-6000 FU (fibrinolytic units) daily have demonstrated nattokinase's ability to reduce blood viscosity by 8-12% and improve circulation markers within 2-8 weeks. A randomized controlled trial with 86 participants showed significant reductions in fibrinogen levels and improved arterial elasticity after 8 weeks of supplementation. Several smaller studies have reported decreased blood pressure and improved lipid profiles, though larger long-term trials are needed to confirm cardiovascular protection. The evidence is promising but still emerging, with most studies having 12-week durations and moderate sample sizes.

Nutritional Profile

- Contains fibrinolytic activity, aiding in blood clot breakdown. - Rich in protein due to its soybean origin. - Contains vitamin K2, important for bone and cardiovascular health.

Preparation & Dosage

Typical dosage ranges from 100 to 200 mg per day. Consult a healthcare provider before use.

Synergy & Pairings

CoQ10, Omega-3, Garlic

Safety & Interactions

Nattokinase can increase bleeding risk and should not be combined with anticoagulant medications like warfarin, heparin, or antiplatelet drugs without medical supervision. Common side effects include mild gastrointestinal upset, and rare cases of allergic reactions have been reported in individuals sensitive to soy products. The supplement should be discontinued at least 2 weeks before surgery due to bleeding concerns. Pregnant and breastfeeding women should avoid nattokinase due to insufficient safety data, and individuals with bleeding disorders or recent strokes should consult healthcare providers before use.